GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.23 Cr | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr | ₹0.40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GENNEX LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-0.23 Cr |
Mar2023 | ₹-0.14 Cr |
Mar2022 | ₹0.00 Cr |
Mar2021 | ₹0.15 Cr |
Mar2020 | ₹0.40 Cr |
How is Deferred Tax Assets / Liabilities of GENNEX LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.23 Cr | Negative | |
Mar2023 | ₹-0.14 Cr | Negative | |
Mar2022 | ₹0.00 Cr | -98.04 | |
Mar2021 | ₹0.15 Cr | -61.65 | |
Mar2020 | ₹0.40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹331.6 Cr | -4.9% | 11% | -4.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -4.9% |
11% |
-4.3% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses